Devin Absher, HudsonAlpha Institute for Biotechnology, AL USA
Ana Domingos, Gulbenkian Science Institute, Portugal
Jian Han, HudsonAlpha Institute for Biotechnology, AL USA
Michael Lotz, University of Pittsburg Medical Center, PA USA
Markus Maeurer, Champalimaud Foundation, Portugal
Francesco Marincola, Refuge Biotechnologies Inc., USA

 

 

Featured Speakers:

Guido Kroemer, Institut Gustave Roussy, Paris, France
Laurence Zitvogel, Institut Gustave Roussy, Paris, France

 

Session Speakers:

Myriam Aouadi, Karolinska Institute, Sweden
Thomas Boehm, Max Planck Institute, Germany
Carlos Cordon-Cardo, Mount Sinai, USA
Henrique Veiga Fernandes, Champalimaud Foundation, Portugal
Ana Domingos, Gulbenkian Science Institute, Portugal
Rita Fior, Champalimaud Foundation, Portugal
Tina Fuchs, University of Heidelberg, Germany
Jerome Galon, Institut National de la Santé et de la Recherche Médicale, FR
Florent Ginhoux, Institute of Medical Biology, A*Star, Singapore
Jennifer L. Gommerman, University of Toronto, CA
Jian Han, HudsonAlpha Institute for Biotechnology, USA
William Hawkins, Washington University, St. Louis Pancreatic, USA
Adrian Hayday, King’s College, UK
Dirk Jager, National Center for Tumor Diseases, Germany
Stefan Kaufmann, Max Planck Berlin
Shabaana Khader, Washington University in St. Louis, USA
Michael Lotze, University of Pittsburgh Medical Center, USA
Markus Maeurer, Champalimaud Foundation, Portugal
Stanlei Lei Qi, Stanford University, USA
Hans-Georg Rammensee, University of Tuebingen, Germany
Theodore Roth, University of California San Francisco, USA
Marco Ruella, University Pennslyvania, USA
Bruno Silva-Santos, Institute of Molecular Medicine, Portugal
Daron Standley, Osaka University, Japan
Bing Sun, Shanghai Immunology Institute, China
Megan Sykes, Columbia University, USA
Dario Vignali, University of Pittsburgh, USA
Eric Vivier, AIX-Marseille University Medical School, France
Ena Wang, Allogene Therapeutics, USA
Yang Yang, Stanford University, USA